Document Detail

Effect of mifegin on the content of cyclic nucleotides in the cervical myometrium in full-term pregnancy.
MedLine Citation:
PMID:  12533756     Owner:  NLM     Status:  MEDLINE    
Cervical myometrium was examined in 22 pregnant women at 39-41 weeks gestation at risk of labor abnormalities. The patients received mifegin for preparing to labor. A new component in the mechanism of mifegin effect on the uterine cervix in full-term pregnancy was revealed: mifegin elevated the content of cAMP by 50% and almost 2-fold increased the cAMP/cGMP ratio compared to the initial level.
P V Sergeev; E N Kareva; N D Gasparyan; V V Podval'nyuk
Related Documents :
15935646 - "ultra-light" patient-controlled epidural analgesia during labor: effects of varying re...
3348306 - Clinical features of small contraction wave recorded by an external tocodynamometer.
1418156 - Creatine kinase and creatine kinase isoenzymes as a marker of uterine activity.
6504426 - Respiratory arrest during therapy for premature labor in a patient with myasthenia gravis.
23404756 - Risk of congenital anomalies in relation to the uptake of trihalomethane from drinking ...
20885996 - Factors associated with the acquisition and severity of gestational listeriosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bulletin of experimental biology and medicine     Volume:  134     ISSN:  0007-4888     ISO Abbreviation:  Bull. Exp. Biol. Med.     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2003-01-20     Completed Date:  2003-11-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372557     Medline TA:  Bull Exp Biol Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  349-50     Citation Subset:  IM    
Department of Molecular Pharmacology, Russian State Medical University, Russia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Cyclic AMP / metabolism*
Cyclic GMP / metabolism*
Drug Administration Schedule
Labor, Obstetric / metabolism
Mifepristone / administration & dosage,  pharmacology*
Myometrium / drug effects,  metabolism*
Pregnancy / metabolism*
Pregnancy Outcome
Reg. No./Substance:
60-92-4/Cyclic AMP; 7665-99-8/Cyclic GMP; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of lipid matrix and cytoskeleton proteins on Ca2+-activated K+ channels in erythrocytes of al...
Next Document:  Relationship between alcohol motivation and ethanol sensitivity and blood and brain catecholamine co...